Nurses Report Improved Workplace Conditions in 2023 Versus 2022
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 23, 2024 -- Nurses reported improved workplace conditions in 2023 versus 2022, according to a study published online July 18 in JAMA Network Open.
Christopher R. Friese, Ph.D., R.N., from the University of Michigan in Ann Arbor, and colleagues sought to identify changes in practicing registered nurses' employment plans and workplace assessments between the 2022 and 2023 surveys. Analysis included participants in the Michigan Nurses' Study at two time points (Feb. 22 to March 1, 2022: 9,150 nurses; May 17 to June 1, 2023: 7,059 nurses).
The researchers found that 32.0 percent of nurses planned to leave their position in 2023 versus 39.1 percent in 2022. Among nurses planning to leave, 41.8 percent planned to leave their current employer but remain in nursing, with workloads cited as the most common reason (29.4 percent). Compared with 2022, respondents in the 2023 survey reported less workplace abuse or violence (50.2 versus 43.4 percent), fewer understaffed shifts (48.2 versus 41.0 percent), and less frequent use of mandatory overtime (18.7 versus 11.7 percent). Increased likelihood for planned departures was associated with workplace abuse or violence (odds ratio, 1.39) and higher emotional exhaustion scores (odds ratio, 3.05). Lower likelihood of planned departure was seen with favorable practice environments (odds ratio, 0.37) and excellent clinical setting safety ratings (odds ratio, 0.28).
"Health system leaders and policymakers should prioritize initiatives that support nurse retention and reduce potential workforce instability," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-24 07:15
Read more
- Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay
- USPSTF Recommends Screening for Domestic Violence in Pregnant, Postpartum Women
- AI Might Help Pick Up Heart Trouble in Dogs
- 2022 to 2023 Saw No Change in U.S. Infant Mortality Rate
- Opioid Use Treatment at Intervention Clinics Continues to Rise for Third Year
- Younger Patients More Affected by Neurologic Manifestations of Long COVID
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions